The Cancer-Associated ATM R3008H Mutation Reveals the Link between ATM Activation and Its Exchange

Area of Science:

• Genetics and Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• ATM kinase is a crucial tumor suppressor regulating DNA damage response.
• Cancer-associated ATM alterations commonly occur in the PI3-kinase regulatory domain (PRD) or kinase domain.
• Kinase-dead ATM protein expression accelerates lymphomagenesis more than complete ATM loss.

Purpose of the Study:

• To investigate the mechanism by which PRD mutations suppress lymphomagenesis.
• To functionally characterize the common cancer-associated PRD mutation R3008H in ATM.
• To understand the distinct role of the PRD in ATM activation and tumor suppression.

Main Methods:

• Introduction of the cancer-associated PRD mutation R3008H (R3016 in mouse) into mice.
• Assessment of ATM activation, protein stability, and recruitment to DNA damage sites.
• Analysis oflymphomagenesis, immunodeficiency, and physical abnormalities in genetically modified mice.

Main Results:

• The R3008H mutation abrogated ATM activation by DNA damage and oxidative stress without affecting protein stability or recruitment.
• Mice with the AtmR3016H mutation were viable and immunodeficient, exhibiting craniofacial abnormalities and delayed lymphomagenesis compared to Atm null mice.
• The R3008H mutation rescued delayed exchange of ATM-kinase-dead at DNA damage foci, indicating PRD's role in coordinating ATM activation and exchange.

Conclusions:

• The PRD mutation R3008H confers a unique tumorigenesis profile distinct from ATM null or kinase-dead mutations.
• The PI3-kinase regulatory domain plays a critical role in ATM activation and DNA damage response coordination.
• Functional characterization of R3008H highlights its significance in cancer and provides insights into ATM regulation.